Predicting the development of Cushing's syndrome in medullary thyroid cancer: utility of proopiomelanocortin messenger ribonucleic acid in situ hybridization.

Source:http://linkedlifedata.com/resource/pubmed/id/17696832

Download in:

View as

General Info

PMID
17696832